Marcan Pharmaceuticals
Canadian pharmaceutical company focused on development, manufacture, marketing and distribution of finished-dose generic medicines for the Canadian market. Operates a portfolio of oral and sterile injectable dosage forms, maintains bilingual product documentation and public product pages with downloadable monographs and patient information, operates pharmacovigilance and post-market safety surveillance programs, and manages API sourcing and regulatory dossiers and Canadian product registrations (DIN management).
Industries
Nr. of Employees
small (1-50)
Marcan Pharmaceuticals
Products
Finished-dose generics portfolio (oral and injectable)
Portfolio of finished-dose generic products across multiple therapeutic classes and dosage forms (immediate- and extended-release orals, orally disintegrating tablets, capsules, sterile injectables, lyophilized powders, emulsions) with public product-detail pages and downloadable bilingual monographs/patient leaflets.
API supply and registration list
Catalog of active pharmaceutical ingredients and associated regulatory documentation status offered for supply or development, including references to regulatory dossier types.
Finished-dose generics portfolio (oral and injectable)
Portfolio of finished-dose generic products across multiple therapeutic classes and dosage forms (immediate- and extended-release orals, orally disintegrating tablets, capsules, sterile injectables, lyophilized powders, emulsions) with public product-detail pages and downloadable bilingual monographs/patient leaflets.
API supply and registration list
Catalog of active pharmaceutical ingredients and associated regulatory documentation status offered for supply or development, including references to regulatory dossier types.
Services
Reimbursement support, patient education, co-pay and financial assistance programs and registry/enrollment services to support patient access and adherence.
Adverse event reporting intake, targeted follow-up questionnaires, and safety data collection workflows for marketed products.
Web publication of DIN-level product detail pages that include therapeutic class, DIN, strengths, formats, pack sizes and downloadable English/French product monographs and patient leaflets (PDF) for marketed products.
Reimbursement support, patient education, co-pay and financial assistance programs and registry/enrollment services to support patient access and adherence.
Adverse event reporting intake, targeted follow-up questionnaires, and safety data collection workflows for marketed products.
Web publication of DIN-level product detail pages that include therapeutic class, DIN, strengths, formats, pack sizes and downloadable English/French product monographs and patient leaflets (PDF) for marketed products.
Expertise Areas
- Finished-dose generic manufacturing
- Sterile injectable manufacturing and lyophilization
- Oral solid dose formulation and controlled-release technologies
- Pharmacovigilance and post-market safety surveillance
Key Technologies
- Sterile manufacturing and aseptic processing
- Lyophilization (freeze-dried parenteral formulations)
- Parenteral formulation methods
- Oral solid dosage and controlled-release formulation technologies
News & Updates
Launch of arsenic trioxide for injection in 10 mL vial format available across Canada (antineoplastic).
Launch of ready-to-use carmustine for injection available across Canada.
Multiple re-launches and new product introductions across 2023–2025 including oral and injectable formulations.
Launch of arsenic trioxide for injection in 10 mL vial format available across Canada (antineoplastic).
Launch of ready-to-use carmustine for injection available across Canada.
Multiple re-launches and new product introductions across 2023–2025 including oral and injectable formulations.